These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25013913)

  • 1. Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.
    Leuenberger T; Pfueller CF; Luessi F; Bendix I; Paterka M; Prozorovski T; Treue D; Luenstedt S; Herz J; Siffrin V; Infante-Duarte C; Zipp F; Waiczies S
    PLoS One; 2014; 9(7):e100871. PubMed ID: 25013913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis.
    Yilmaz A; Reiss C; Tantawi O; Weng A; Stumpf C; Raaz D; Ludwig J; Berger T; Steinkasserer A; Daniel WG; Garlichs CD
    Atherosclerosis; 2004 Jan; 172(1):85-93. PubMed ID: 14709361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
    Shachaf CM; Perez OD; Youssef S; Fan AC; Elchuri S; Goldstein MJ; Shirer AE; Sharpe O; Chen J; Mitchell DJ; Chang M; Nolan GP; Steinman L; Felsher DW
    Blood; 2007 Oct; 110(7):2674-84. PubMed ID: 17622571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
    Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
    Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.
    Mausner-Fainberg K; Luboshits G; Mor A; Maysel-Auslender S; Rubinstein A; Keren G; George J
    Atherosclerosis; 2008 Apr; 197(2):829-39. PubMed ID: 17826781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase.
    Cao Z; Fan-Minogue H; Bellovin DI; Yevtodiyenko A; Arzeno J; Yang Q; Gambhir SS; Felsher DW
    Cancer Res; 2011 Mar; 71(6):2286-97. PubMed ID: 21262914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway.
    Hu LH; Zhang T; Shao Q; Li DD; Jin SX; Nie P; Yi J; He B; Shen LH
    Mol Cell Biochem; 2012 Dec; 371(1-2):105-13. PubMed ID: 22890916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
    Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity.
    Ness GC; Chambers CM; Lopez D
    J Lipid Res; 1998 Jan; 39(1):75-84. PubMed ID: 9469588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
    Morikawa S; Umetani M; Nakagawa S; Yamazaki H; Suganami H; Inoue K; Kitahara M; Hamakubo T; Kodama T; Saito Y
    J Atheroscler Thromb; 2000; 7(3):138-44. PubMed ID: 11480454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated enzyme inhibition assay method for the determination of atorvastatin-derived HMG-CoA reductase inhibitors in human plasma using radioactivity detection.
    Valesky RJ; Liu L; Musson DG; Zhao JJ
    J Pharmacol Toxicol Methods; 2008; 57(1):61-9. PubMed ID: 17651990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE.
    Mix E; Ibrahim SM; Pahnke J; Glass A; Mazón-Peláez I; Lemcke S; Koczan D; Gimsa U; Bansemer S; Scheel T; Karopka T; Böttcher T; Müller J; Dazert E; Antipova V; Hoffrogge R; Wree A; Zschiesche M; Strauss U; Kundt G; Warzok R; Gierl L; Rolfs A
    J Autoimmun; 2006 Dec; 27(4):251-65. PubMed ID: 17085013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
    Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
    Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
    Wilcox LJ; Barrett PH; Huff MW
    J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFNalpha treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression.
    López P; Gutiérrez C; Suárez A
    Clin Immunol; 2008 Nov; 129(2):350-9. PubMed ID: 18757244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity.
    Shimabukuro-Vornhagen A; Zoghi S; Liebig TM; Wennhold K; Chemitz J; Draube A; Kochanek M; Blaschke F; Pallasch C; Holtick U; Scheid C; Theurich S; Hallek M; von Bergwelt-Baildon MS
    J Immunol; 2014 Nov; 193(10):5294-305. PubMed ID: 25311809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY; Fedtsov A; Madias NE
    Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.